How is ECoG used in a clinical trial?

ECOG Performance Status. This numbering scale is one way to define the population of patients to be studied in the trial, so that it can be uniformly reproduced among physicians who enroll patients. It is also a way for physicians to track changes in a patient’s level of functioning as a result of treatment during the trial.

What does Eastern Cooperative Oncology Group ( ECoG ) mean?

Eastern Cooperative Oncology Group (ECOG) Performance Status. Determines ability of patient to tolerate therapies in serious illness, specifically for chemotherapy, simpler than the Karnofsky Scale. Patients with active cancer under treatment. The ECOG Performance Status is a simple measure of functional status.

How are ECoG and Karnofsky performance status used?

The ECOG Performance Status and the Karnofsky Performance Status are two widely used methods to assess the functional status of a patient. Both scales have been in the public domain for many years as ways to classify a patient according to their functional impairment, compare the effectiveness of therapies, and assess the prognosis of a patient.

When to take ECOG performance status into consideration?

Researchers worldwide take the ECOG Performance Status into consideration when planning trials to study a new treatment method. This numbering scale is one way to define the population of patients to be studied in the trial, so that it can be uniformly reproduced among physicians who enroll patients.

How can I find out about ECoG-ACRIN clinical trials?

The buttons below depict the general research categories being investigated in ECOG-ACRIN clinical trials. To access information within a particular category, click on the relevant button. Upon clicking, the color of the button will change from grey to red, and a table will appear on screen.

When did the ECOG cancer scale come out?

The scale was developed by the Eastern Cooperative Oncology Group (ECOG), now part of the ECOG-ACRIN Cancer Research Group, and published in 1982.